Abstract:Abstract Abstract 1215 Sirt1 is a NAD+-dependent class III histone deacetylase that regulates various cellular processes including cell growth, apoptosis, senescence and stress responses. Variations in Sirt1 expression and activity are associated with pleiotropic and profound biological effects that are often cell context-dependent. Here we tested the impact of enhanced Sirt1 activity in normal and BCR-ABL1-dependent leukemic haematopoiesis in vitro. Using 5-FU enriched murine primary hematopoietic stem and progenitor cells (HSPC) as a model, we report that: 1. Sirt1 over-expression induces 2–3 fold increased, both in frequency and absolute number, of HSPC cells (Lin-Sca1+ckit+) in ‘stem cell-like’ culture condition and enhanced clonogenicity in serial transplantation assay. qRT-PCR analysis showed significantly higher expression of GATA-2 gene in HSPC cells suggesting that Sirt1 promotes GATA-2 mediated HSPC cell proliferation. 2. When HSPC cells were induced to differentiation in the presence of lineage specific growth factor EPO, G-CSF and IL-7, respectively, Sirt1 expression significantly increased the frequency and absolute number of terminal differentiated erythroid (ter119+, 2–3 folds), granulocytic (Gr-1+Cd11b+, 2–3 folds) and B (B220+CD19+, 3–4 folds) cells. Thus, enhanced Sirt1 activity promotes HSPC self-renewal and multiple lineage differentiation. We next tested the effects of Sirt1 activity in Chronic Myeloid Leukaemia (CML). By transducing Sirt1 retrovirus into IL3-dependent BaF3, IL3-independent BCR-ABLp210-expressing BaF3 and primary HSPC cell, we found that Sirt1 over-expression significantly inhibited BCR-ABL1-driven cell proliferation and clonogenicity in cytokine depleted media. In addition, Sirt1 over-expression further reduced the growth rate of BCR-ABLp210 expressing BaF3 cells when treated with TGF-b1, suggesting that Sirt1 might play as a downstream effector of TGF-b signal. Finally, Resveratrol (RSV), a Sirt1 activator, alone and in co-operation with Imatinib, induced cell death and inhibited clonogenicity of CD34+ cells from CML patients with chronic phase. Taken together, our data demonstrate that Sirt1 exhibits contrasting effects in normal and BCR-ABL1-dependent haematopoiesis and suggest that manipulating Sirt1 activity may be a useful strategy to differentially promote normal and inhibit leukemic haematopoiesis in CML. Disclosures: No relevant conflicts of interest to declare.

Loss of SIRT1 inhibits hematopoietic stem cell aging and age-dependent mixed phenotype acute leukemia

Sirt1 Protects Subventricular Zone-Derived Neural Stem Cells from DNA Double-Strand Breaks and Contributes to Olfactory Function Maintenance in Aging Mice

SIRT1 Ameliorates Age-Related Senescence of Mesenchymal Stem Cells Via Modulating Telomere Shelterin

GW24-e2135 SIRT1 Significantly Influences Old Sourced MSCs Aging and Proliferation

Sex-dependent differences in hematopoietic stem cell aging and leukemogenic potential

Activation of SIRT1 Deacetylase As a Therapeutic Approach for Myelodysplastic Syndromes By Restoring TET2 Function

Abstract 10153: SIRT1 Activation Restores Cardioprotection in the Aged Heart Against Ischemia/Reperfusion Injury

SIRT1 Regulates the Phosphorylation and Degradation of P27 by Deacetylating CDK2 to Promote T-cell Acute Lymphoblastic Leukemia Progression.

Role of SIRT1 in Hematologic Malignancies.

SIRT1 Activation Disrupts Maintenance of Myelodysplastic Syndrome Stem and Progenitor Cells by Restoring TET2 Function

SIRT7: an influence factor in healthy aging and the development of age-dependent myeloid stem-cell disorders

Integrated Single-Cell Bioinformatics Analysis Reveals Intrinsic and Extrinsic Biological Characteristics of Hematopoietic Stem Cell Aging

SIRT7 antagonizes human stem cell aging as a heterochromatin stabilizer

Loss of ATF4 Leads to Functional Aging-Like Attrition of Adult Hematopoietic Stem Cells

Contrasting Effects Of Enhanced Sirt1 Activity In Normal And Bcr-Abl1-Depedent Haematopoiesis

Autophagy‐Sirt3 axis decelerates hematopoietic aging

3216 – GENOTOXIC FORMALDEHYDE ACCELERATES AGEING IN HEMATOPOIETIC STEM CELLS IN A P53-DRIVEN MANNER

Loss of sphingosine kinase 2 promotes the expansion of hematopoietic stem cells by improving their metabolic fitness

Age-related Noncanonical TRMT6–TRMT61A Signaling Impairs Hematopoietic Stem Cells

Transplantation of SIRT1-engineered aged mesenchymal stem cells improves cardiac function in a rat myocardial infarction model.

Reducing functionally defective old HSCs alleviates aging-related phenotypes in old recipient mice